(Foto: Jyrki Siikanen)
Prof. Ann-Christine Syvänen
Ann-Christine.Syvanen@medsci.uu.se
Address:
Molecular Medicine
Department of Medical Sciences
Entrance 70, 3rd floor
Research dept. II
University Hospital
SE-751 85 UPPSALA
The research group in Molecular Medicine headed by Professor Ann-Christine Syvänen was started in 1998. The group studies human diseases using modern technology for genomics.
Professor Syvänen also heads the SNP&SEQ Technology Platform that offers genotyping and next generation sequencing services and training to academic researchers. The SNP&SEQ Technology Platform is also a part of the genomics platform of Science for Life Laboratory in Uppsala.
We co-organize courses in molecular medicine and massively parallel sequencing targeted at students of different levels.
A good overview of our group can be read in a recent EU-publication
Use the tab-menu above to view information about our research, courses and services.
2011-12-14
Molecular Medicine research group has received funding from the Swedish Childhood Cancer Foundation.
2011-11-17
VR-RFI has granted 6.7 million SEK for running costs to the SNP&SEQ platform.
2011-10-04
Molecular Medicine research group has received funding from the K&A Wallenberg foundation.
2011-08-11
A study that doubles the number of susceptibility genes for multiple sclerosis (MS) was published in Nature on Aug 11.
2011-06-20
The SNP&SEQ Technology Platform have now upgraded our Genome Analyzer IIx with a HiSeq 2000 instrument from Illumina.
2011-03-06
Five new loci for coronary artery disease were published on-line in Nature Genetics on March 6th.
2011-01-18
The Molecular Medicine group contributes to the ESGI infra-structure by technology development, eg. allele-specific gene expression and epigenetics.
